Immunic’s (IMUX) “Buy” Rating Reiterated at D. Boral Capital
D. Boral Capital reiterated their buy rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report released on Wednesday morning,Benzinga reports. They currently have a $10.00 target price on the stock. IMUX has been the topic of several other reports. Wall Street Zen downgraded shares of Immunic from a “hold” rating to a […]
D. Boral Capital reiterated their buy rating on shares of Immunic (NASDAQ:IMUX – Free Report) in a report released on Wednesday morning,Benzinga reports. They currently have a $10.00 target price on the stock. IMUX has been the topic of several other reports. Wall Street Zen downgraded shares of Immunic from a “hold” rating to a […]
